Page 2 - ஜார்ஜ் கொத்தனார் பல்கலைக்கழகம் இருக்கிறது வர்ஜீனியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Tetra Bio-Pharma Initiates Additional Studies on Leading Drug Candidate ARDS-003
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
Tetra Bio-Pharma Initiates Additional Studies on Leading Drug Candidate ARDS-003
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Nearly half of poison control calls for supersized alcopops involve underage drinkers
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Dr. Michelle Williams, an expert in developing culturally appropriate interventions for cancer prevention, led the study published in the Journal of Health Disparities Research and Practice. view more
Credit: George Mason University
African American breast cancer survivors are four times more likely to die from breast cancer than women of all other races and ethnicities, and they have a disproportionately high rate of death from cardiovascular disease (CVD).
New research led by George Mason University s College of Health and Human Services faculty Dr. Michelle Williams assessed African American breast cancer survivors risk factors and knowledge about CVD in the Deep South, where health disparities between African American women and women of other races is even larger. They found that although African American breast cancer survivors have a higher prevalence of CVD risk factors, their knowledge about CVD is low.
E-Mail
IMAGE: Lance Liotta, MD, PhD, study PI, and George Mason University College of Science CAPMM co-founder and co-director. view more
Credit: Evan Cantwell, George Mason University
A George Mason University and Rutgers Cancer Institute of New Jersey collaboration received the U.S. Army s Breast Cancer Research Program (BCRP) Breakthrough Award to quickly confirm if an identified HER2 biomarker can indicate success likelihood of personalized breast cancer treatments.
George Mason University s College of Science announced an exciting $1.33 million collaboration with Rutgers Cancer Institute of New Jersey and Mason s Center for Applied Proteomics and Molecular Medicine (CAPMM) which taps cancer research diagnostics and treatment strengths within the medical facilities and CAP/CLIA laboratory respectively of the two regional powerhouses.